Cencora, Inc.
General ticker "COR" information:
- Sector: Health Care
- Industry: Medical - Distribution
- Capitalization: $62.0B (TTM average)
Cencora, Inc. does not follow the US Stock Market performance with the rate: -16.1%.
Estimated limits based on current volatility of 1.5%: low 301.03$, high 310.09$
Factors to consider:
- Company included in S&P500 list
- Company pays dividends (irregularly): last record date 2026-05-15, amount 0.60$ (Y0.19%)
- Total employees count: 51000 (+10.9%) as of 2025
- Top business risk factors: Customer loss, Acquisition/divestiture risks, Regulatory and compliance, Cybersecurity threats, Labor/talent shortage/retention
- Price in estimated range
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-09-30 to 2027-09-30
- 2025-09-30 to 2026-09-30 estimated range: [246.87$, 362.23$]
- 2026-09-30 to 2027-09-30 estimated range: [262.76$, 385.30$]
Financial Metrics affecting the COR estimates:
- Negative: with PPE of 18.7 at the end of fiscal year the price was very high
- Positive: 6.62 < Operating cash flow per share per price, % of 6.67
- Positive: 1.77 < Return on assets ratio (scaled to [-100,100]) of 2.01
- Positive: -5.34 < Operating profit margin, % of 1.14
- Positive: 0.02 < Industry earnings per price (median), % of 1.15
- Positive: -9.70 < Industry operating profit margin (median), % of 0.54
- Negative: 0.01 < Interest expense per share per price, % of 0.50
- Positive: -14.27 < Investing cash flow per share per price, % of -8.57
- Negative: Shareholder equity ratio, % of 1.97 <= 19.19
Short-term COR quotes
Relationship graph
Long-term COR plot with estimates
Financial data
| YTD | 2023-09-30 | 2024-09-30 | 2025-09-30 |
|---|---|---|---|
| Operating Revenue | $262,173.41MM | $293,958.60MM | $321,332.82MM |
| Operating Expenses | $259,832.68MM | $291,783.35MM | $318,704.22MM |
| Operating Income | $2,340.73MM | $2,175.25MM | $2,628.60MM |
| Non-Operating Income | $-179.90MM | $-171.27MM | $-370.26MM |
| Interest Expense | $228.93MM | $156.99MM | $291.55MM |
| Income(Loss) | $2,160.84MM | $2,003.97MM | $2,258.34MM |
| Taxes | $428.26MM | $484.70MM | $690.52MM |
| Net Income(Loss)* | $1,745.29MM | $1,509.12MM | $1,554.17MM |
| Stockholders Equity | $522.00MM | $645.94MM | $1,508.02MM |
| Inventory | $17,454.77MM | $18,998.83MM | $20,492.48MM |
| Assets | $62,558.75MM | $67,101.67MM | $76,590.11MM |
| Operating Cash Flow | $3,911.33MM | $3,484.68MM | $3,875.12MM |
| Capital expenditure | $458.36MM | $487.17MM | $667.98MM |
| Investing Cash Flow | $-2,602.47MM | $-618.10MM | $-4,977.29MM |
| Financing Cash Flow | $-2,222.28MM | $-2,330.99MM | $2,249.11MM |
| Earnings Per Share** | $8.53 | $7.60 | $8.02 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.